These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 31347498)

  • 1. Nephrotoxicity of amikacin in noncritically ill patients
.
    Kim DJ; Lee J; Yu H; Lee DH; Kang T; Han YK; Kim DH; Kim SW
    Clin Nephrol; 2019 Oct; 92(4):201-207. PubMed ID: 31347498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic monitoring of amikacin and gentamicin in critically and noncritically ill patients.
    Kovačević T; Avram S; Milaković D; Špirić N; Kovačević P
    J Basic Clin Pharm; 2016 Jun; 7(3):65-9. PubMed ID: 27330257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zileuton ameliorates aminoglycoside and polymyxin-associated acute kidney injury in an animal model.
    Hudson CS; Smith JE; Eales BM; Kajiji S; Liu X; Truong LD; Tam VH
    J Antimicrob Chemother; 2023 Oct; 78(10):2435-2441. PubMed ID: 37563789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Administration of higher doses of amikacin in early stages of sepsis in critically ill patients.
    Najmeddin F; Ahmadi A; Mahmoudi L; Sadeghi K; Khalili H; Ahmadvand A; Najafi A; Mojtahedzadeh M
    Acta Med Iran; 2014; 52(9):703-9. PubMed ID: 25325208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of Amikacin Drug Exposure and Nephrotoxicity in an Animal Model.
    Chan K; Ledesma KR; Wang W; Tam VH
    Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32571819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aminoglycoside nephrotoxicity: comparative assessment in critically ill patients.
    Plaut ME; Schentag JJ; Jusko WJ
    J Med; 1979; 10(4):257-66. PubMed ID: 294466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between colistin dose and development of nephrotoxicity.
    Lee YJ; Wi YM; Kwon YJ; Kim SR; Chang SH; Cho S
    Crit Care Med; 2015 Jun; 43(6):1187-93. PubMed ID: 25756417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative Incidence of Acute Kidney Injury in Critically Ill Patients Receiving Vancomycin with Concomitant Piperacillin-Tazobactam or Cefepime: A Retrospective Cohort Study.
    Hammond DA; Smith MN; Painter JT; Meena NK; Lusardi K
    Pharmacotherapy; 2016 May; 36(5):463-71. PubMed ID: 26952639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure to predict amikacin elimination in critically ill patients with cancer based on the estimated glomerular filtration rate: applying PBPK approach in a therapeutic drug monitoring study.
    Telles JP; Diegues MS; Migotto KC; de Souza Borges O; Reghini R; Gavazza BV; Pinto L; Caruso P; E Silva ILF; Schmidt S; de Lima Moreira F
    Eur J Clin Pharmacol; 2023 Jul; 79(7):1003-1012. PubMed ID: 37256410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness, nephrotoxicity, and therapeutic drug monitoring of polymyxin B in nosocomial pneumonia among critically ill patients.
    Ye Q; Wang Q; Chen Z; Chen W; Zhan Q; Wang C
    Clin Respir J; 2022 May; 16(5):402-412. PubMed ID: 35586931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study of ototoxicity and nephrotoxicity in patients randomly assigned to treatment with amikacin or gentamicin.
    Lerner SA; Schmitt BA; Seligsohn R; Matz GJ
    Am J Med; 1986 Jun; 80(6B):98-104. PubMed ID: 3524221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative nephrotoxicity and tissue accumulation of dactimicin, amikacin and gentamicin.
    Bonadio M; Maccanti O; Giovannini L; Bertelli AA; Scalori V; Alessandrì MG; Bertelli A
    Drugs Exp Clin Res; 1987; 13(12):747-50. PubMed ID: 3447878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship Between Initial Vancomycin Trough Levels and Early-Onset Vancomycin-Associated Nephrotoxicity in Critically Ill Patients.
    Chuma M; Makishima M; Imai T; Tochikura N; Suzuki S; Kuwana T; Sawada N; Komatsu T; Sakaue T; Kikuchi N; Yoshida Y; Kinoshita K
    Ther Drug Monit; 2018 Feb; 40(1):109-114. PubMed ID: 29095798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic impact of standard antibiotic therapy combined with amikacin, in clinical unit, Lodz, Poland--part II.
    Kusowska J
    Acta Pol Pharm; 2005; 62(6):491-5. PubMed ID: 16583990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the Effects of a High Amikacin Dose on Plasma Peak Concentration in Critically Ill Children.
    Medjebeur Hanna R; Levy M; Bille E; Hennequin C; Lesage F; Naudin J; Moulin F; Blanquer M; Béranger A; Renolleau S; Oualha M; Genuini M
    Paediatr Drugs; 2021 Jul; 23(4):395-401. PubMed ID: 34142330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic impact of standard antibiotic therapy combined with amikacin, in clinical unit, Lodz, poland--part I.
    Kusowska J
    Acta Pol Pharm; 2005; 62(6):485-90. PubMed ID: 16583989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute kidney injury in non-critically ill children treated with aminoglycoside antibiotics in a tertiary healthcare centre: a retrospective cohort study.
    Zappitelli M; Moffett BS; Hyder A; Goldstein SL
    Nephrol Dial Transplant; 2011 Jan; 26(1):144-50. PubMed ID: 20591815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vancomycin-associated nephrotoxicity in the critically ill: a retrospective multivariate regression analysis*.
    Hanrahan TP; Harlow G; Hutchinson J; Dulhunty JM; Lipman J; Whitehouse T; Roberts JA
    Crit Care Med; 2014 Dec; 42(12):2527-36. PubMed ID: 25083977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative nephrotoxicity of hydroxygentamicin and other aminoglycosides in rats.
    Slighter RG; Montenaro MJ; Fabian RJ; Bhandari JC; Donikian MR; Drobeck HP
    Fundam Appl Toxicol; 1984 Aug; 4(4):558-67. PubMed ID: 6479501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum cystatin C level for better assessment of glomerular filtration rate in cystic fibrosis patients treated by amikacin.
    Halacova M; Kotaska K; Kukacka J; Vavrova V; Kuzelova M; Ticha J; Prusa R
    J Clin Pharm Ther; 2008 Aug; 33(4):409-17. PubMed ID: 18613859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.